Main Article Content
In the article on the basis of the literature there has been considered the statistics of average consumption of lactose in the countries of the world community, reviewed the clinical significance of the excess lactose in the diet depending on the polymorphism of the lactase gene. Lactose is the main source of energy for the children of the first months of life, which provides about 40–45 % of the daily energy needs of a body of a child. Lactose malabsorption, deficiency of the enzyme lactase is accompanied by symptoms of lactose intolerance. Interest in the study of the influence of an immunomodulatory β-galactoside lactose was caused by the suppression of its galectin 9 (Gal-9), the regulatory T-cell immune response involving T-helper cells 1 and 17 (Th1, Th17) and regulatory T-lymphocytes (Treg), which are involved in many immune-mediated human diseases. Galectin 9 is the representative of the class of galectins such as «tandem repeat». The highest level of LGALS9 expression is observed in the tissues of colon, lung, bone marrow, lymph nodes, thymus, liver, kidney, endocrine glands, placenta, skin, smooth muscle, adipose tissue.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Abaturov AA, Nikulina AA, Petrenko LL. [The role of lactase deficiency in children]. International Journal of Pediatrics, Obstetrics and Gynecology]. 2015; 2(7): 51-62. Russian.
Abaturov AA, Stepanova YuYu, Nikulina AA. [Persistence and lack of lactase]. Pediatrics. Eastern Europe. 2015; 3(11): 31-43. Russian.
Hulich MP, Polishchuk TV. [Availability calcium children: the role of dairy products, ways of correction]. Еnvironment & health. 2012; 4:61-65. Ukrainian.
Delyagin VM, Kagramanova KG, Shugurina EG. i dr. [Lactase gene polymorphism in children with atopic diseases]. Pediatrics. 2008; 87(4):16-24. Russian.
Brüssow H. Nutrition, population growth and disease: a short history of lactose. Environ Microbiol. 2013;15:2154–61. doi: 10.1111/1462-2920.12117.
Burger J, Kirchner M, Bramanti B et al. The lactase-persistence-associated allele in early Neolithic Europeans. Proc. Natl. Acad. Sci. USA. 2007; 104: 3736–3741. doi: 10.1073/pnas.0607187104.
Campbell AK, Naseem R, Holland IB et al. Methylglyoxal and other carbohydrate metabolites induce lanthanum-sensitive Ca2+ transients and inhibit growth in E. coli. Arch. Biochem. Biophys.2007 Dec 1;468(1):107-113. doi: 10.1016/j.abb.2007.09.006.
Cooper DNW, Barondes SH. God must love galectines. He made so many of them. Glicobiology.1999; 9 (10):979–984. PMID: 10521533.
Deng Y, Misselwitz B, Dai N et al. Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients. 2015;7(9):8020-35. doi: 10.3390/ nu70953804.
Fang R. The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation. Gastroenterology 2000; 118 ( 1): 115-127. doi:10.1016/S0016-5085(00)70420-3.
Geng H, Zhang GM, Li D, Zhang H, Yuan Y, Zhu HG, et al. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol. 2006;176(3):1411–20. doi: 10.4049/jimmunol.176.3.1411.
Heaney RP Dairy in take, dietary adequacy, and lactose intolerance. Adv. Nutr. 2013; 4(2):151-156. doi: 10.3945/an.112.003368.
Ji J, Sundquist JK, Sundquist N. Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden. Br J Cancer. 2015, Jan 6;112(1):149-52. doi: 10.1038/bjc.2014.544.
Keryer-Bibens C, Pioche-Durieu C, Villemant C et al. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer. 2006; 6: 283. doi: 10.1186/1471-2407-6-283.
Lhuillier C, Barjon C, Niki T et al. Impact of exogenous galectin-9 on human T cells: contribution of the T cell receptor complex to antigen-independent activation but not to apoptosis induction. J. Biol. Chem. 2015; 290(27). doi:10.1074/jbc.M115.661272.
Matsumoto R, Matsumoto H, Seki M, Hata M. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998;273:16976-16984. . doi: 10.1074/jbc.273.27.16976.
Mattar R, Mazo DF. Intolerância à lactose: mudança de paradigmas coma biologia molecular. Rev. Assoc. Med. Bras. 2010; 56(2):230-236.doi.org/10.1590/S0104-42302010000200025.
Misselwitz B, Pohl D, Frühauf H . Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterol. J. 2013; 1(3):151-159. doi: 10.1177/2050640613484463.
Pereira PC Milk nutritional composition and its role in human healt. Nutrition. 2014; 30(6):619-627. doi: 10.1016/j.nut.2013.10.011.
Prentice A.M. Dairy products in global public health. Am J Clin Nutr. 2014 May;99(5):1212-1216. doi:10.3945/ajcn.113.073437.
Saita N, Goto E, Yamamoto T et al. Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol. 2002;128:42–50. doi:10.1159/000058002.
Savaiano DA, Ritter AJ, Klaenhammer TR, James GM, Longcore AT, Chandler JR et al. Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. Nutr. J. 2013; 12:160;35. doi: 10.1186/1475-2891-12-160.
Sehrawat S, Reddy PB, Suryawanshi A et al. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J Immunol. 2011 Dec 1;187(11):5745-55. doi: 10.4049/ jimmunol.1102105.
Sharon N. Lectins: Past, present and future. Biochem Soc Trans. 2008; 36:1457–1460. doi:10.1042/BST0361457.
Smithson G, Rogers CE, Smith PL, Scheidegger EP. Selectin Ligand Expression and Recruitment in Inflammation, and Together with Fuc-TIV Regulates Naive T Cell Trafficking to Lymph Nodes. The Journal of Experimental Medicine. 2001;194: 601–614. PMC219 5944.
Soriа С. Milk Consumption Per Capita Worldwide. Food Beast: Map of Milk Consumption & Lactose Intolerance Around the World. 2015 Dec 29; 12:345-364.
Suchy FJ, Brannon PM, Carpenter TO et al. NIH consensus development conference statement: Lactose intolerance and health. NIH Consens State Sci Statements. 2010; 27(2):1-27// http://consensus.nih.gov.
Than NG, Romero R, Balogh A. et al. Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia. J. Pathol. Transl. Med. 2015 May; 49(3):181-208. doi: 10.4132/jptm. 2015. 02.25. Epub 2015 May 1; http: //www.ncbi.nlm.nih.gov/gene.
Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin’s disease. J Biol Chem 1997;272:6416-6422. doi:10.1074/jbc.272.10.6416.
Vladoiu MC, Labrie M, St-Pierre Y. Intracellular galectins in cancer cells: potential new targets for therapy (Review). Int J Oncol. 2014;44(4):1001-14. doi: 10.3892/ijo. 2014.2267.
Wang Y, Harvey CB, Pratt WS et al. The lactase persistence/non-persistence polymorphism is controlled by a cis-acting element. Hum Mol Genet. 1995; 4(4):657-62.doi: 10.1093/hmg/4.4.657.
Wahlqvist ML Lactose nutrition in lactase nonpersisters. Asia Pac J Clin Nutr. 2015 Dec;24(1):21-5. doi: 10.6133/apjcn.2015.24.s1.04.
Wilt TJ, Shaukat A, Shamliyan T et al. Lactose intolerance and health. Evid Rep Technol Assess (Full Rep). 2010 Feb;(192):1-410. PMID:20629478.
Yoshida H, Imaizumi T, Kumagai M. et al. Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuroreport. 2001;12:3755–3758. doi: 10.1371/journal. pone. 0009504.
Zheng X, Chu H, Cong Y et al. Self-reported lactose intolerance in clinic patients with functional gastrointestinal symptoms: Prevalence, risk factors, and impact on food choices. Neurogastroenterol. Motil. 2015;27:1138–1146. doi: 10.1111/nmo.12602.